Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Genetronics starts trials of cancer drug delivery:

This article was originally published in Clinica

Executive Summary

Trials of Genetronics' electric field-based drug delivery system have begun at nine US centres to test the effectiveness of the technique on difficult-to-treat head and neck cancers. The company, from San Diego California has developed the electroporation therapy that creates temporary pores in cells using electric fields into which drugs can enter. The Phase II trial will follow 25 patients and further sites will join the study. Patients in France and Canada are also being treated for head and neck cancers.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT081315

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel